SCCM
Log In
Forgot username or password?
New User? Sign Up Free.

Tag: ARDS

Concise Critical Appraisal: Dexamethasone Use in the Treatment of ARDs
Villar et al (Lancet Respir Med. 2020;8:267-276) attempted to demonstrate the effect of steroids in patients with moderate to severe acute respiratory distress syndrome (ARDS) along with modern standard ICU practices, including lung-protective mechanical ventilation.

ARDS, Concise Critical Appraisal


Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital
From Pediatric Critical Care Medicine. This study aims to describe a series of children admitted to a pediatric intensive care unit in Spain, one of the countries severely affected by the coronavirus. disease 2019 (COVID-19).

ARDS, Coronavirus, COVID-19


SCCM Pod-408 Vaping-Associated Respiratory Distress Syndrome
Kyle B. Enfield, MD, and Craig M. Lilly, MD, discuss the newly released guidance for vaping-associated respiratory distress syndrome, published in Critical Care Explorations (Lilly C, et al. Crit Care Explor. 2020;2(2): e0081).

ARDS, Poisoning


Disparities in the Use of Corticosteroids for ARDS Caused by COVID-19 by Different Organizations: What Is the Right Answer?
Steve Pastores, MD, co-author of the Critical Care Explorations article "Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019," discusses the disparities in the use of corticosteriod treatment for ARDS caused by COVID-19 by different organizations. This is SCCM curated COVID-19 microlearning content.

ARDS, Coronavirus, COVID-19, Therapies


SCCM Pod-417 COVID-19-Associated Acute Respiratory Distress Syndrome
Clinicians are working to understand and formulate an effective treatment for COVID-19-associated acute respiratory distress syndrome (Marini J. Crit Care Med. 2020 May 13; Epub ahead of print).

ARDS, Coronavirus, COVID-19


Editorial: Dealing With the CARDS of COVID-19
From Critical Care Medicine. An editorial associated with the Mauri et al. article on personalized ventilation for COVID-19 ARDS patients.

ARDS, Coronavirus, COVID-19


Is the COVID-19 disease process more similar to high-altitude pulmonary edema than to classic acute respiratory distress syndrome?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on April 15, 2020.

ARDS, Coronavirus, COVID-19


Letter to the Editor: Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome
From Criticial Care Explorations. The authors report on the use of corticosteroids in mechanically ventilated patients with SARSCoV-2 related acute respiratory distress syndrome.

ARDS, Coronavirus, COVID-19, Diagnosis and Testing, Therapies


Letter to the Editor: Evidence of Steroids in Patients With Acute Respiratory Distress Syndrome in Coronavirus Disease 2019
From Critical Care Explorations. A letter to the editor in response to Villar et al. article on corticosteroids and COVID-19.

ARDS, Coronavirus, COVID-19, Therapies


Letter to the Editor: Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
From Critical Care Explorations. To do better understand the risk factors associated with pulmonary embolism in patients with COVID-19, the authors performed a post hoc analysis from the COVADIS project, a multicenter observational study gathering 21 ICUs from France and Belgium.

ARDS, Coronavirus, COVID-19


Online Letter to the Editor: Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance
From Critical Care Medicine. The authors share the following opinions on the recruitment-response COVID-19 ARDS patients, 1) bronchiolitis, in a histologic context, is a plausible pathophysiological mechanism, and 2) a simple bedside physiologic test could potentially determine recruitment potential in resource-limited settings.

ARDS, Coronavirus, COVID-19, Supportive Care


Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019
From Critical Care Medicine. Severe cases of coronavirus disease 2019 develop the acute respiratory distress syndrome, requiring admission to the ICU. This study aims to describe specific pathophysiological characteristics of acute respiratory distress syndrome from coronavirus disease 2019.

ARDS, Coronavirus, COVID-19, Hemodynamic Support, Supportive Care, Ventilatory Support


Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist
From Critical Care Explorations. As the SARS-CoV-2 pandemic develops, assays to detect the virus and infection caused by it are needed for diagnosis and management. In this article, the authors describe to clinicians how each assay is performed, what each assay detects, and the benefits and limitations of each assay.

ARDS, Coronavirus, COVID-19, Diagnosis and Testing


SCCM Pod-417 COVID-19-Associated Acute Respiratory Distress Syndrome
Clinicians are working to understand and formulate an effective treatment for COVID-19-associated acute respiratory distress syndrome (Marini J. Crit Care Med. 2020 May 13; Epub ahead of print).

ARDS, coronavirus, COVID-19, Disaster Preparedness, Supportive Care, Ventilatory Support


The Rationale for the Use of Prolonged Corticosteroid Treatment for ARDS Caused by COVID-19
Steve Pastores, MD, co-author of the Critical Care Explorations article "Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019," discusses the use of corticosteriod treatment for ARDS caused by COVID-19. This is SCCM curated COVID-19 microlearning content.

ARDS, Coronavirus, COVID-19, Therapies


What are the prospective benefits of proning for COVID-19-associated acute respiratory syndrome (ARDS)? Does proning management for non-COVID-19-associated ARDS differ from that for COVID-19-associated ARDS?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 8th, 2020.

ARDS, Coronavirus, COVID-19


What are your thoughts about using glucocorticoids in patients with severe ARDS secondary to COVID-19 who remain intubated after 7 days?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

ARDS, Coronavirus, COVID-19, Intubation, Therapies, Ventilatory Support


What is new in the treatment of acute respiratory distress syndrome in COVID-19 patients?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 10th, 2020.

ARDS, Coronavirus, COVID-19


What Is the Rationale for Using Corticosteroids to Treat Acute Respiratory Failure in COVID-19 Patients?
Steve Pastores, MD, co-author of the Critical Care Explorations article "Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019," answers question regarding the use of corticosteriod treatment for ARDS caused by COVID-19. This is SCCM curated COVID-19 microlearning content.

ARDS, Coronavirus, COVID-19, Therapies